John Johnson, Director at Xeris Biopharma Holdings, Inc. (XERS), sold 135,400 shares at $7.22 ($978K) on 2025-12-19, disclosed to the SEC on 2025-12-19.
Open-market sale of $978k XERS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AXGN | SELL | 2025-12-10 | $2.8M | — | Filing → |
| XERS | SELL | 2025-08-15 | $787K | — | Filing → |
| AXGN | SELL | 2025-06-11 | $43K | — | Filing → |